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Synopsis 
A training program for detecting the ultrasound signs associated with placenta accreta 
spectrum using a standardized protocol improves the diagnostic accuracy. 
 
ABSTRACT  
Objective: To evaluate the impact of a training program using a systematic protocol on 
ultrasound signs of placenta accreta spectrum (PAS). 
Methods: Intra- and inter-observer variability rates and sensitivity were tested, before and 
after additional training, by two research fellows with a prior basic training in obstetric 
ultrasound using digitally recorded second-trimester ultrasound images from cases of 
anterior placenta previa with and without PAS. 
Results: Fifty-two cases of anterior placenta previa with PAS (n=26) and without PAS 
(n=26) were included in the study. The highest level of inter-observer agreement for 
ultrasound signs was found for the absence of placental bulge and/or focal exophytic mass 
on gray-scale imaging and the absence of subplacental hypervascularity, bridging vessels 
and lacunar feeder vessels on color Doppler imaging. The level of inter-observer agreement 
increased from 39% before training to 40% after training; the numbers agreed as PAS by 
both trainees increased from four to 20. No cases were classified as inconclusive after 
training. There was a significant (P<0.001) change in sensitivity for both trainees after 
training. 
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Conclusion: Additional training in detecting the ultrasound signs associated with PAS using 
a standardized protocol improves the diagnostic accuracy of operators with only a basic 
obstetric ultrasound training. 
 
1 INTRODUCTION 
When undiagnosed antenatally, placenta accreta spectrum (PAS) is often associated with 
massive obstetric hemorrhage due to attempts by the surgical operator to detach the 
placenta from the uterine wall during delivery [1, 2]. Prenatal diagnosis has been shown to 
lead to better maternal outcomes and has thus become essential in improving the 
management of PAS [3, 4]. However, recent large prospective population studies have 
shown that PAS remains undiagnosed before birth in one-half [2] to two-thirds of cases [5].  
The first prenatal ultrasound description of placenta accreta was reported by Tabsh 
et al. [6] in 1982. In the following 25 years, 1078 cases, including 38 case reports and 53 
series of PAS diagnosed during pregnancy by expert operators, were reported in the 
international literature [7]. Placenta previa accreta has become the most common 
presentation of PAS [8] and the overall performance of ultrasound in diagnosing accreta 
placentation in patients presenting with low-lying/placenta previa in expert centers is 
excellent, with a sensitivity of 88%–97% and specificity of 90%–97% [9]. 
In most countries, screening for fetal abnormalities with ultrasound is now an integral 
part of routine antenatal care and many high- and middle-income countries have specific 
prenatal ultrasound training courses for healthcare professionals. The majority of routine 
anomaly scanning around the world is still performed in the second trimester, at 18–22 
weeks. Over the last two decades, an increasing number of fetal abnormalities have been 
detected at 11–14 weeks of gestation with rates of detection of first- 
trimester fetal anomalies ranging from 32% in low-risk groups to more than 60% in high-risk 
groups [10]. Of the factors examined for their impact on the rate of detection, the use of 
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standardized anatomical protocols has been shown to significantly improve the sensitivity of 
ultrasound examination for the detection of fetal anomalies in all subgroups [11].  
Until recently, there was no standardized protocol for the ultrasound diagnosis of 
PAS. Many two-dimensional (2D) gray-scale and color Doppler imaging (CDI) signs were 
reported in the literature with varying descriptions as to their sensitivity and specificity, 
confusing terminology and, in many cases, a lack of confirmation of diagnosis at birth [7, 11]. 
To improve consistency and allow appropriate comparison of different imaging markers, 
panels of experts have published consensus statements aiming to standardize the 
descriptions and minimum requirements for an ultrasound scan to diagnose PAS [12]. The 
incidence of each of these ultrasound signs in cases of PAS has recently been evaluated, 
with detailed clinical and pathologic diagnosis and the proportion of agreement between 
experts. It was found that most of these signs are useful in the prenatal diagnosis of PAS 
[13]. The aim of the present study was to prospectively evaluate the impact of additional 
training and the use of a standardized examination protocol on the diagnostic accuracy of 
ultrasound in PAS and how this training could be used for the ultrasound screening of 
women at risk of PAS in the general population. 
2 MATERIALS AND METHODS 
The ultrasound images of 52 cases of placenta previa with (n=26) and without PAS (n=26) 
were reviewed at the Fetal Medicine Research Institute (FMRI) by two newly appointed 
research fellows (LFDB and WA) who had only a basic training in routine obstetric 
ultrasound. All prenatal ultrasound records were examined within the research center, basic 
clinical data were collected using a standard clinical audit protocol, and all images 
were anonymized for data analysis. This study was approved by the NHS Research Ethics 
committee (reference 18/WM/0328). 
 For each case, the trainees were given access to 15–20 2D gray-scale and CDI 
digitally recorded images per case obtained at 20–28 weeks of gestation by both 
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transabdominal and transvaginal sonography (TVS) using standard ultrasound equipment 
(GE Voluson 730, GE Medical System, Zipf, Austria) and a standard protocol [13]. The 
images were reviewed by the trainees before and after additional specific training. For the 
review of ultrasound images, ultrasound signs from the standardized descriptions were used 
[12], including: for gray-scale imaging: loss of clear zone, myometrial thinning, the presence 
of placental lacunae, bladder wall interruption, placental bulge, and focal exophytic mass; 
and for CDI: utero-vesical hypervascularity, subplacental hypervascularity, bridging vessels, 
and lacunae feeder vessels. The trainees were instructed to identify at least two ultrasound 
markers to make a diagnosis of PAS. They were blind to the clinical diagnosis at birth and to 
each other’s examination results. 
Six weeks after their first examination, the research fellows independently repeated 
their examination, following an expert tuition session modelled on the online training 
modules for the diagnosis of fetal abnormalities from the Fetal Medicine Foundation 
(www.fetalmedicine.org). 
Statistical analysis 
The data were analyzed using Stata/IC version 15.0 (StataCorp LLC, TX, USA). As the 
distributions were skewed, continuous data are presented as medians and interquartile 
ranges (IQR). Because of the uneven distribution of values among cells, some of the kappa 
values are unstable, as indicated by negative values despite high agreement; the 
percentage agreement was used, as previously described [15, 16]. A binomial test of 
significance was conducted to assess whether there was evidence of higher agreement in 
the third trimester rather than the second trimester. A χ2 test was conducted to compare 
sensitivity before and after training. A P value less than 0.05 was considered significant. 
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3 RESULTS 
The PAS study group included 10 cases of placenta creta (Adherenta), 10 cases of placenta 
increta, and six cases of placenta percreta confirmed clinically at delivery and by subsequent 
detailed histopathological examination by a perinatal pathologist. All cases of PAS were 
managed by primary peri-partum hysterectomy. In all cases, the placenta was mainly 
anterior reaching or covering the internal cervical os on TVS at mid-gestation and confirmed 
at 32–34 weeks of gestation. The non-accreta study group included 26 cases of anterior 
placenta previa classified using the same ultrasound criteria. All women in both groups had 
an obstetric history of one or more prior cesarean deliveries (median 2; IQR 1–2) and were 
all delivered by cesarean. All cases in the PAS group had a planned cesarean-
hysterectomy. All the ultrasound images reviewed by the trainees were obtained during the 
mid-pregnancy (median 21 weeks; IQR 20–22) detailed fetal anatomy scan using the same 
ultrasound equipment (GE Voluson 730, GE Medical System, Zipf, Austria).  
The results of the independent examination by the trainees before and after the 
additional training are presented in Table 1. Before training, the highest level of inter-
observer agreement for ultrasound signs was found for the absence of placental bulge 
and/or focal exophytic mass on gray-scale imaging and the absence of subplacental 
hypervascularity, bridging vessels and lacunar feeder vessels on CDI. The inter-observer 
degree of agreement increased after training for the presence of myometrial thinning, 
placental lacunae, utero-vesical and subplacental hypervascularity. After training, both 
trainees also agreed in all cases, that there was placental bulge and/or focal exophytic mass 
on gray-scale imaging. 
Table 2 displays the overall classification made by the trainees before and after 
training. The level of agreement increased from 39% before training to 40% after training; 
the numbers agreed as PAS by both trainees increased from four to 20. No cases were 
classified as inconclusive after training compared to four graded inconclusive by trainee 1 
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and one graded inconclusive by trainee 2, both before training. Before training, trainee 1 had 
no false-positive cases and 18 false-negative cases; trainee 2 had three false-positive cases 
and 21 false-negative cases. After training, trainee 1 had six false-positive cases and five 
false-negative cases; trainee 2 had six false-positive cases and seven false-negative cases. 
For both trainees, there was a statistically significant (P<0.001) change in sensitivity after 
training (Table 3).  
   
4 DISCUSSION 
The present study is the first to evaluate the impact of a specialist training for the prenatal 
diagnosis modelled on existing training modules for the diagnosis of fetal anomalies. Overall, 
we found that an additional training in detecting the ultrasound signs associated with PAS 
using a standardized protocol significantly improves the diagnostic sensitivity of operators 
with only a basic obstetric ultrasound training.  
A recent prospective longitudinal study including women with placenta previa and at 
least one prior cesarean delivery or uterine surgery showed that using three ultrasound 
signs improved the rate of detection for placenta percreta with a sensitivity of 100% (95% 
confidence interval [CI] 92.6–100) and a specificity of 77.2% (95% CI 69.9–83.4) [17]. This 
study and the cohort studies included in recent systematic reviews are reported expert 
teams and thus these data cannot be applied to the general population of women who are 
provided with a routine mid-trimester fetal anatomy scan by non-expert ultrasonographers. 
The data from the present study show that an additional training modelled on an existing 
teaching module developed to improve the knowledge of sonographers in the diagnosis of 
fetal anomalies is associated with increased diagnostic sensitivity of PAS in women 
presenting with anterior placenta previa and history of prior cesarean delivery. 
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In the present study, we used the standardized descriptions of the ultrasound 
markers associated with PAS and the corresponding reporting protocol proposed recently by 
the European Working Group on Abnormally Invasive Placenta (EW-AIP) and the AIP 
international expert group [12, 13]. Using the same descriptions, we have previously 
reclassified the ultrasound findings of case reports and cohort studies on the prenatal 
ultrasound diagnosis of PAS [7]. It was found that in the 72 cases that provided detailed 
correlations between ultrasound findings and PAS grading, a loss of clear zone (62.1%) and 
the presence of bridging vessels (71.4%) are the most common ultrasound signs found in 
cases of placenta adherenta or creta (non-invasive PAS) whereas a loss of clear zone 
(84.6%) and subplacental hypervascularity (60%), and placental lacunae (82.4%) and 
subplacental hypervascularity (54.5%) are the most common ultrasound signs found for 
placenta increta and placenta percreta, respectively. No ultrasound sign or a combination of 
ultrasound signs are specific to the depth of accreta placentation. The detection of these 
signs with transabdominal ultrasound varies with maternal bladder filling, direct pressure of 
the ultrasound probes, myometrial contractions, and gestational age [11, 18]. TVS can 
circumvent some of these issues and is essential to locate the edge of the placenta in cases 
of placenta previa accreta; however, its use is only reported by less than-half of authors of 
expert cohort studies [9]. For each case, the trainees were provided with images obtained 
with both transabdominal ultrasound and TVS, suggesting that both ultrasound techniques 
should be included in a training program. 
The impact of invasive PAS is mainly at the level of the deep uterine circulation, and 
transformation of the radial and arcuate arteries and the development of neo-vascularization 
lead to major anatomical changes under the placental bed and in the placental cotyledon 
above the accreta area [11]. The corresponding signs—i.e. loss of clear zone, intraplacental 
lacunae, and lacunar feeder vessels—were the most commonly identified signs in the 
present study and in previous studies [7]. It was recently found that these signs are 
associated with the highest level of inter-observer agreement between experts [14]. In the 
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present study, there was complete agreement between the trainees for the absence of 
placental bulge and/or focal exophytic mass on gray-scale imaging after training. These 
signs are almost exclusively seen in the most invasive and extended cases of PAS [7] and 
were only found in around 10% of  cases during the third trimester ultrasound examination 
[14]. By contrast, myometrial thinning is a consequence of prior cesarean scar [11] and not a 
consequence of accreta placentation but this ultrasound sign has been commonly reported 
in retrospective observational cohort studies [7]. Not surprisingly, due to the strong 
association between prior caesarean deliveries and anomalies of placentation, this sign is 
associated with a high level of inter-observer of agreement between experts in both the 
second and third trimesters [14]. However, the trainees agreed on the absence of 
myometrial thinning in only 32/52 of the cases included in the present study and the 
corresponding level of agreement did not change after training. These findings suggest that 
the development of a protocol for screening PAS during routine mid-trimester scans would 
require a simplified version of the list of ultrasound signs reported by experts.  
 
 
 In the UK, most routine prenatal ultrasound examinations are performed by 
ultrasonographers with no medical training; thus, they are less likely to be aware of the risk 
factors associated with the development of PAS. The risk of both placenta previa and PAS is 
higher in women with a history of cesarean delivery [8, 19–21]. The incidence of placenta 
previa accreta increases with the numbers of prior cesarean deliveries from 4.1% in women 
with one prior cesarean to 13.3% in women with two or more previous cesareans [9]. These 
risks are independent of other maternal characteristics, such as parity, body mass index, 
tobacco use, and coexisting hypertension or diabetes [8]. Cesarean deliveries are not the 
only cause of PAS [22, 23] but following the exponential rise in the rate of cesarean delivery 
in many countries around the world, placenta previa accreta has become the most common 
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presenting type of PAS, found in more than 95% of the cases [9]. Thus, ultrasound operators 
should be made aware that women with a previous history of cesarean deliveries, presenting 
with an anterior low-lying placenta or placenta previa in the second trimester of pregnancy, 
have become the largest group of women with the highest risk of PAS. 
 Our study is limited by the number of trainees involved and the present data need to 
be evaluated on a larger scale. The strengths of the present study included the use 
standardized ultrasound signs and reporting protocol for the pre- and post-training diagnostic 
evaluations. The increase in sensitivity of the two research fellows with only a prior basic 
training in general obstetric ultrasound indicates that, as for fetal structural defects, the 
prenatal detecting of PAS can be improved using a similar training strategy. The results of 
well-conducted prospective cohort studies [24,25] have shown that the sensitivity and 
specificity of gray-scale imaging alone in diagnosing placenta previa accreta are high when 
performed by experienced operators, suggesting that CDI and three-dimensional ultrasound 
may not be essential for the screening of accreta placentation. These findings and our data 
indicate that operators in low-resource countries with access to basic ultrasound equipment 
only can be trained remotely using on-line training programs to diagnose PAS prenatally and 
thus improve the management and outcome of this complex obstetric complication. 
In conclusion, the vast majority of women at high risk of PAS will have a routine mid-
trimester fetal anatomy scan in a local hospital by ultrasonographers with no or limited 
experience of examining the placenta. High reproducibility and low inter-observer variability 
of ultrasound imaging of PAS are essential to implement a screening program for women at 
high risk of PAS. Unlike magnetic resonance imaging, ultrasound imaging is operator-
dependent; thus, the additional training based on ultrasound signs with excellent or good 
inter-observer agreement should improve the diagnostic accuracy of ultrasound in women 
with PAS. 
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Table 1. Inter-observer agreement for the ultrasound signs used in the diagnosis of PAS in 
the second trimester before and after training. 
Ultrasound signs Pre-training agreement (%) Post-training agreement 
(%) 
Gray-scale parameters   
1. Loss of clear zone 67.3 67.3 
2. Myometrial thinning 71.1 86.5 
3. Placental lacunae 88.5 88.5 
4. Bladder wall interruption 86.5 88.5 
5. Placental bulge 94.2 100 
6. Focal exophytic mass 94.2 100 
CDI parameters   
7. Utero-vesical HV 63.5 75.0 
8. Subplacental HV 71.1 80.8 
9. Bridging vessels 86.5 80.8 
10. Lacunae feeder vessels 75.0 73.1 
Abbreviations: CDI, color Doppler imaging; HV, hypervascularity. 
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Table 2. Overall classification made by the trainees before and after training. 
Variable  Placenta previa PAS Inconclusive 
Before training    
Placenta previa 35 4 4 
PAS 4 4 0 
Inconclusive 1 0 0 
After training    
Placenta previa 20 5 - 
PAS 7 20 - 
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Table 3. Accuracy for diagnosis of PAS before and after training for both trainees. 
Variable Before training (% (95% 
CI)) 
After training (% (95% CI)) 
Trainee 1   
SN a 30.8 (14.3–51.8) 80.8 (60.6–93.4) 
SP 100.0 (86.8–100.0) 76.9 (56.4–91.0) 
PPV 100.0 (63.1–100.0) 77.8 (57.7–91.4) 
NPV 59.1 (43.2–73.7) 80.0 (59.3–93.2) 
PLR - 3.5 (1.69–7.24) 
NLR 0.69 (0.54–0.89) 0.25 (0.11–0.57) 
Trainee 2   
SN b 19.2 (6.6–39.4) 73.1 (52.2–88.4) 
SP 88.5 (69.8–97.6) 76.9 (56.4–91.0) 
PPV 62.5 (24.5–91.5) 76.0 (54.9–90.6) 
NPV 52.3 (36.7–67.5) 74.1 (53.7–88.9) 
PLR 1.67 (0.44–6.26) 3.17 (1.51–6.63) 
NLR 0.91 (0.72–1.15) 0.35 (0.18–0.68) 
Abbreviations: SN, sensitivity; SP, specificity, PPV, positive predictive value; NPV, negative 
predictive value; PLR, positive likelihood ratio; NLR, negative likelihood ratio. 
a Comparison in SN. Trainee 1: χ2 15.94; df=2; P=0.00034. 
b Comparison in SN. Trainee 2: χ2 14.05; df=2; P=0.00088 
 
 
 
